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Abstract
In this paper, we consider the joint modelling of survival and longitudinal data with
informative observation time points. The survival model and the longitudinal model
are linked via random eects, for which no distribution assumption is required under
our estimation approach. The estimators are shown to be consistent and asymptotically
normal. The proposed estimator and its estimated covariance matrix can be easily
calculated. Simulation studies and an application to a primary biliary cirrhosis study
are also provided.
Keywords: Cox model; informative observation times; log-normal distribution; longitu-
dinal data; multistate models.
1 Introduction
The motivation for this paper arose from a primary biliary cirrhosis (PBC) study (Mur-
taugh et al., 1994). The PBC is a chronic, fatal, but rare liver disease characterized
by inammatory destruction of the small bile ducts within the liver, which eventually
leads to cirrhosis of the liver. Patients often present abnormalities in their blood tests,
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such as elevated and gradually increased serum bilirubin. The research interest is to
study how the drug D-penicillamine (DPCA) aects event times and how the patterns
of time courses of bilirubin levels aect death due to PBC. Patients in this study will
have their blood tests roughly at 6 months, 1 year, and annually thereafter. Longi-
tudinal measurements (such as bilirubin levels) will be collected at these time points.
These predetermined time points are independent of the longitudinal measurements,
however, some longitudinal observations may be observed at an `extra' visit, which is
often undertaken unexpectedly because of worsening medical condition. Therefore, such
an observation time point is informative to the longitudinal measurement. For survival
events, a patient in this study may experience a single event, death/transplant (or cen-
soring); or may experience a death/transplant (or censoring) event and an extra visit to
clinic(implying worsening medical condition).
Multiple event models such as multistate models (Andersen and Keiding, 2002; Meira-
Machado et al., 2009) are suitable for modelling the extra-visit event and death event.
To incorporate the eects of longitudinal measurements, we consider a joint analysis of
multiple event models for the survival data and linear mixed eect models for the longitu-
dinal measurements, where the dependency on the informative observation time points
is also considered. The sub-models are joint via a common biomarker process. Such
joint models for longitudinal data and survival events have been well developed, when
the observation times for longitudinal data are non-informative. Henderson et al. (2000)
demonstrated the advantage of using a joint modelling approach. Recent developments
in this area include Han et al. (2007) for joint models of a longitudinal biomarker and
recurrent events; Elasho et al. (2008) for joint modelling of competing risks models and
longitudinal models; and Dantan et al. (2011) for joint analysis of multi-state models and
longitudinal models. Note that the longitudinal model in Dantan et al. (2011) involves
a change point and they use two dierent linear models for the longitudinal data before
and after the change point. Their model requires that all longitudinal observations are
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collected at non-informative time points. In our study, however, the last longitudinal
observation may be observed in the extra visit, which is informative. Readers may see
Tsiatis and Davidian (2004) for a detailed review of joint modeling of survival events
and longitudinal measurements.
The main challenge for the PBC study, which cannot be solved by the existing methods, is
the informative observation time points for longitudinal measurements, the `extra visit'.
There has been a vast literature for dealing with informative observation time points for
longitudinal data, e.g. Lin et al. (2004); Sun et al. (2007); Liang et al. (2009); Huang
et al. (2006); Chen et al. (2015), but these methods focus on longitudinal observations
without a terminating survival event or with an independent stopping event. More
recent studies focus on longitudinal data with informative observation time points or
with informative dropouts. For example Liu et al. (2008) developed a joint random
eect model, with the random eect distribution specied, for longitudinal data with
informative observation time points and dependent terminal event. Sun et al. (2012)
provided a joint analysis of longitudinal data with informative observation times and a
dependent terminal event via two latent variables. Their focus is on the eects of the
observed covariates rather than how the unobserved biomarker aects the survival events.
In their estimation approach, the distribution of the latent variables are unspecied, but
the asymptotic covariance matrix is estimated via a Monte Carlo resampling approach.
Han et al. (2013) developed a joint modelling approach for longitudinal observations
using a semiparametric regression, observation processes and the dropout process using
an accelerated failure time model.
To our knowledge, although many methods for joint modelling of multiple survival events
and longitudinal data have been developed, joint analysis for multiple survival event and
longitudinal data with informative observation times has been hardly studied. In this
paper we develop a working-likelihood approach to deal with such problems. This new
method has several innovations. First, our method needs neither to impute the latent
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random eects nor to integrate out the latent variables from the likelihood. Instead, our
method estimates the latent biomarker process via Least Squares estimates, which are
actually functions of other unknown parameters in the longitudinal model. Then such
Least Squares estimate functions are plugged into the survival model and we can further
obtain unbiased estimating equations for all unknown parameters. The proposed method
gives a very simple asymptotic covariance matrix estimator, which is easy to compute.
Monte Carlo resampling approach is not needed as that in Sun et al. (2012). Second,
the new method does not need to specify any distribution for the random eects. This
new method is an extension of the corrected score methods in Wang (2006) and Song
and Wang (2008). Third, our method can provide not only the eects of the observed
covariates on survival events but also how the unobserved biomarker process aects
survival event rates.
This paper is organised as follows. The preliminaries and statistical models are intro-
duced in Section 2. Then we introduce the new methodology, and provide the estimating
equations, the consistent estimators and the asymptotic normality in Section 3. Sim-
ulation studies and an application to the primary biliary cirrhosis study are given in
Section 4 and Section 5, respectively. Section 6 gives a brief discussion.
2 Notations and the statistical model
We denote the death event time as Ti, which is usually subject to random censoring
by Ci. We can only observe Xi = minfTi; Cig and i = I[Ti  Ci]. Let Yi(t) denote
the longitudinal process at time t, which is observed intermittently either at time points
ti1 < ti2 <    < ti;ni (these times are usually planned in advance and are independent
of the longitudinal process Yi(t)), except that the last time point may be an extra
(random) visit Ri = ti;ni related to Yi(t)). The observation time Ri means that at this
time point the patient visits the clinic unexpectedly. Therefore this `extra' observation
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time point Ri will be informative, for example representing worsening medical condition.
We assume that each patient has at most one informative time points, for simplicity
and because this is the scenario in the application data set. In general, more than
one informative time points could be observed for each patient. The proposed method
can be easily extended to such general scenarios (see further discussions in Section 6).
For simplicity and without loss of generality, we also assume that there is one time-
independent covariate W i, which corresponds to the treatment or other factors. Note
that our method is applicable for time-dependent covariatesW i(t), if it can be observed
at all time t.
Before presenting the model for Yi(t), we introduce the counting processes for the death
events and the `extra' visits. We consider a two-state transition model for the death
event and the `extra' visit. For the multistate process, state 0 means alive (the initial
state); state 1 means alive but medical condition becomes worse and state 2 means
dead. We here only allow transitions from 0 to 1, 0 to 2 and 1 to 2. We dene N ihl(t) =
#f direct transitions from h to l; in [0; t] for subject ig and Nhl(t) = n 1
P
iN
i
hl(t). A
review for multi-state models can be found in Andersen and Keiding (2002).
We consider the longitudinal model
Yi(t) = i(t) + HfN i01(t)g+ i(t) (1)
where i(t) is the unobserved biomarker process for subject i before medical condition
worsening, i(t)  N(0; 2) and HfN i01(t)g is a function depending on the counting
process related to Ri. This function HfN i01(t)g is able to model how Yi(t) changes at or
after the informative time point. Without the term HfN i01(t)g, the random eect i(t)
will be estimated with bias and then this will further distort other parameter estimates.
If there are multiple informative times, the function H can be chosen as the number of
informative times within a small neighborhood of t (Sun et al., 2005). In our study, there
is at most one informative time. We can choose, for example, HfN i01(t)g = I[Ri < t].
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For simplicity, we denote Hi(t) := HfN i01(t)g. The random process i(t) is modelled by
i(t) = vi0+vi1t+  +viqtq. In our study, we do not specify any distribution assumption
on the random eect vi = (vi0; vi1;    ; viq).
Dene Fi(t) as the ltration generated by fN ihl(s); 0  s  t; hl = 01; 02; 12g, W i and
vi. The individual rate of the counting processes N
i
hl(s) is modelled as a product of
a baseline transition rate and a subject specic factor that depends on the covariates
and the individual's biomarker process i(t) + Hi(t ). The biomarker process has a
change point at the informative observation time. In summary, we consider the following
models,
dhl;i(t) = dhl;0(t) exp

 0hlW i + hl(i(t) + Hi(t ))
	
: (2)
In model (2), parameter hl shows the eects of time independent covariates such as
treatment on the transition rate from state h to state l. Similarly parameter hl shows
the eects of the underlying biomarker process on the transition rate. Notation dhl;0(t)
means the baseline transition rate from state h to state l.
Equivalently, with the notation hl = (hl; hl) and  = (;01;12;02; 
2), we can
also write the above model as
E[dN ihl(t)jFi(t )] = Qihl(t;)dhl;0(t) (3)
Qihl(t;) = exp

 0hlW i + hl(i(t) + Hi(t ))
	
H ihl(t):
where H i01(t) = H
i
02(t) = I[minfRi; Xig  t] and H i12(t) = I[Xi  t > Ri]. Note that
here if Ri did not occur we let Ri = 1 for convenience. Since we choose HfN i01(t)g =
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I[Ri < t], the formula for Q
i
hl can also be written as
Qi01(t;) = exp

 001W i + 01i(t)
	
I[Ri  t];
Qi02(t;) = exp

 002W i + 02i(t)
	
I[Xi  t];
Qi12(t;) = exp

 012W i + 12(i(t) + )
	
I[Xi  t > Ri]: (4)
The above joint models are very general comparing to some existing works. If we choose
i(t) = 0(t) to be the same for all subjects and choose hl = 0 for all (hl), then the
above joint model can be solved using the method in Sun et al. (2005). If we set  = 0,
i(t) = ai0(t) for some random eect ai and unknown function 0(t) and we only
consider the death (censoring) event, then the above model becomes that in Ding and
Wang (2008). The above survival model can also be amended easily to t the survival
data with multiple failure times in Elasho et al. (2008).
3 The statistical inference
In this section, we focus on the parameter estimations in the models (1) and (3). The
challenge here is to deal with the unknown process i(t). One may specify a particular
distribution for vi and based on this distribution assumption, integrate out the latent
variables from the likelihood function (Dantan et al., 2011). However, an inappropriate
distribution assumption may distort the nal estimation results and if many unknown
random eects are involved the numerical integration or EM algorithms will be unstable
(Ding and Wang, 2008). Therefore, we here consider an approach without requiring any
distribution assumption on vi.
A simple idea is, given all the longitudinal observations for Yi(t) and , to replace i(t)
with its Least Squares estimate ^i(t;) (as a function of ) in the (partial) likelihood.
This simple idea, however, will give biased estimates (Henderson et al., 2000). But
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it is possible to use ^i(t;) with certain adjustments in the likelihood function or the
estimating equations to obtain a consistent estimate. One way of doing this is to use the
method based on sucient statistics in Tsiatis and Davidian (2001) or the corrected score
method (Wang, 2006). These methods, however, are only valid when the longitudinal
data are collected at noninformative times. This paper uses the log-normal distribution
property to correct the bias. Note that for any Gaussian random variable  with mean
 and variance 
2
 we have that E[e
] = e+
2
=2. Therefore e 
2
=2 can be used as an
unbiased estimate for e . This log-normal distribution property will help us to nd an
unbiased estimate for ei(t), the exponential of the random eect process, which will be
part of the proportional hazard model.
3.1 The working likelihood function
We here consider an extension of the corrected score approach. Suppose that subject
i has ni longitudinal observations, ni > q + 1. If  is given, we can estimate vi based
on all longitudinal observations of subject i and calculate the predicted value ^i(t;).
If denoting Y i = (Yi(ti1);    ; Yi(ti;ni))0 and Hi = (Hi(ti1);    ;Hi(ti;ni))0, we have that
^i(t;) = (1; t;    ; tq)(T0iTi) 1T0i(Y i   Hi), where Ti is the design matrix with ni
rows and q+1 columns; the rst column has all 1s and the kth column has values tk 1ij ,
k  2. Using standard results from linear regression, given i(t), the predicted value
^i(t;) is normally distributed with mean i(t) and variance 
2
i (t) = 
2bi(t), where
bi(t) = (1; t;    ; tq)(T0iTi) 1(1; t;    ; tq)0:
Recall that Qihl(t;), dened in (3), is a term used to construct the estimating equations
for Cox regression models. Details can be found in Fleming and Harrington (1991) and
Andersen et al. (1993). Since Qihl is not available (due to the unknown random eects),
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we consider using
~Qihl(t;) = exp

 0hlW i + hl(^i(t;) + Hi(t)) 
2hl
2
i (t)
2

~H ihl(t) (5)
instead, where ~H ihl(t) = I[ni > q + 1]H
i
hl(t). We know that, given i(t) = vi 
(1; t;    ; tq)0, the term exp(hl^i(t;)) follows a log-normal distribution and
E
h
exp

hl^i(t;)  
2
hl
2
i (t)
2

jvi
i
= I[ni > q + 1] exp(hli(t)). In addition, given Ft  ,
we also have E
h
~Qihl(t;)jFt 
i
= I[ni > q + 1]Q
i
hl(t;). Therefore it is natural to use
~Qihl(t;) to construct the estimating equations. The idea here is to replace Q
i
hl(t;) by
~Qihl(t;) in the standard Cox partial likelihood function and then the estimating equa-
tions can be obtained by taking derivatives with respect to parameters  and hl and
2.
With the arguments above, we consider the working likelihood function (for the survival
sub-model)
~l() =
Y
hl
Y
i
Y
t
2664 exp

 0hlW i + hl(^i(t;) + Hi(t)) 
2hl
2
i (t)
2

P
j exp

 0hlW j + hl(^j(t;) + Hj(t)) 
2hl
2
j (t)
2

~Hjhl(t)
3775
d ~N ihl(t)
:
where d ~N ihl(t) = I[ni > q + 1]dN
i
hl(t). Then the working log-partial likelihood function
(for the survival sub-model) is
log ~l() =
X
hl
X
i
Z 
 0hlW i + hl(^i(t;) + Hi(t)) 
2hl
2
i (t)
2
  log

~S
(0)
hl (t;)

d ~N ihl(t): (6)
where ~S
(0)
hl (t;) := n
 1P
i
~Qihl(t;).
On the other hand, since  is normally distributed, we also have the following log-
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likelihood function for 2 based on the longitudinal sub-model
X
i
I[ni > q + 1]
24 (ni   q   1) log(2)  (2) 1 niX
j=1
(Yi(tij)  ^i(tij ;)  Hi(tij))2
35 : (7)
Therefore the sum of (6) and (7) will give us the working log-likelihood function.
Note that in Tsiatis and Davidian (2001) 2 can be estimated directly based on (7)
and then we replace the estimate ^2 in (6) to estimate the other parameters. This is
because in their model ^i can be estimated directly and (7) does not involve the unknown
parameter . In our study, we need to consider the likelihood as the sum of (6) and (7)
and estimate all parameters of  = (;01;12;02; 
2) simultaneously.
3.2 The unbiased estimating equations
We can get the estimating equations, based on the derivative for the log-likelihood. First,
we need to introduce the notations ~S
(1)
;hl(t;),
~S
(1)
;hl(t;) and
~S
(1)
;hl(t;) as the rst-order
partial derivatives of ~S
(0)
hl (t;) with respect to hl,  and 
2, respectively. We also
introduce the notations ~S
(2)
;;hl(t;),
~S
(2)
;;hl(t;), ~S
(2)
;;hl(t;),
~S
(2)
;;hl(t;),
~S
(2)
;;hl(t;)
and ~S
(2)
;;hl(t;) as the second-order partial derivatives for
~S
(0)
hl (t;) with respect to hl,
 and 2, respectively. The formulas for these derivatives can be found in Appendix
(equations (15), (16) and (17)).
The estimating equations are given by
U() =

U();U01()
0;U12()
0;U02()
0; U()
0
= 0
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for the unknown parameters , where
U() = n
 1
nX
i=1
Z 1
0
X
hl
24hl(mi(t) +Hi(t))  ~S(1);hl(t;)
~S
(0)
hl (t;)
35 d ~N ihl(t)  n 1 nX
i=1
Fi(; 
2)
Uhl() = n
 1
nX
i=1
Z 1
0
264
0B@ W i
^i(t;) + Hi(t)  hl2i (t)
1CA  ~S(1);hl(t;)
~S
(0)
hl (t;)
375 d ~N ihl(t) (8)
U() = n
 1
nX
i=1
Z 1
0
X
hl
24 1
2
2hl  bi(t) 
~S
(1)
;hl(t;)
~S
(0)
hl (t;)
35 d ~N ihl(t)  n 1 nX
i=1
Ei(; 
2)
where
Ei(; 
2) := I[ni > q + 1]
"
(ni   q   1) 
Pni
j=1(Yi(tij)  ^i(tij ;)  Hi(tij))2
2
#
  2;
Fi(; 
2) = I[ni > q + 1]
niX
j=1
2(Yi(tij)  ^i(tij ;)  Hi(tij))(mi(tij) +Hi(tij))   2
and mi(t) is the derivative of ^i(t;) with respect to , given by (14) in Appendix.
Note that given a parameter value  we can calculate the function U() given above,
since no latent random eects vi are involved. The expressions of U() and U()
have extra terms n 1
P
i Fi and n
 1P
iEi, which are based on the likelihood from the
longitudinal data only. We should expect that such estimating equations give consistent
estimates, which is shown in the following section.
3.3 Large sample properties of the estimate
Denote the true model parameters as  and hl;0. Based on the arguments in Section
3.1, i.e. ~Qihl is an unbiased version for Q
i
hl, we also have that 
 and hl;0 satisfy the
model
dhl;i(t) = dhl;0(t) exp

 0hlW i + hl(^i(t;) + Hi(t )) 
2hl
2
i (t)
2

: (9)
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Therefore, we only need to show the large sample properties under model (9), which
does not involve the unknown random eects.
If we dene Gi(t), as the ltration generated by fN ihl(s); 0  s  t; hl = 01; 02; 12;W i;Y ig
where Y i denotes the longitudinal observations, then ~N
i
hl(t) is adapted to Gi(t) and
model (9) can be written as
E[d ~N ihl(t)jGi(t )] = dhl;0(t) exp

 0hlW i + hl(^i(t;) + Hi(t )) 
2hl
2
i (t)
2

~H ihl(t)
= dhl;0(t) ~Q
i
hl(t;)
~H ihl(t) (10)
This implies that dM ihl(t) = d
~N ihl(t)   ~Qihl(t;)dhl;0(t) is a martingale with respect
to the ltration Gi(t). Based on this we can show that the solution of the estimating
equations gives a consistent estimate, i.e. ^ ! , the true parameter value. This is
given in Appendix.
To establish the asymptotic normality for the estimator, we rst consider the asymptotic
normality for the estimating equations. We can show that
p
nU()! N (0;); as n!1
for some matrix  . This can be easily seen from the facts 1) Ei and Fi (i = 1;    ; n)
are i.i.d. random variables and 2) the function U() can be rewritten in terms of
martingale representation, as
U(
) = n 1
nX
i=1
Z 1
0
X
hl
24hl(mi(t) +Hi(t))  ~S(1);hl(t;)~S(0)hl (t;)
35 dM ihl(t)  n 1 nX
i=1
Fi(; 
2)
Uhl(
) = n 1
nX
i=1
Z 1
0
264
0B@ W i
^i(t;) + Hi(t)  hl2i (t)
1CA  ~S(1);hl(t;)
~S
(0)
hl (t;
)
375 dM ihl(t) (11)
U(
) = n 1
nX
i=1
Z 1
0
X
hl
24 1
2
hl
2bi(t) 
~S
(1)
;hl(t;
)
~S
(0)
hl (t;
)
35 dM ihl(t)  n 1 nX
i=1
Ei(
; 2):
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Note that the correlation of dM ihl(t) and Ei (or Fi) is 0, since E[dM
i
hl(t)jGi(t )] = 0 and
Ei (or Fi) is measurable with respect to Gi(t ).
If we dene d Nhl(t) = n
 1P
i d
N ihl(t),
^hl;0(t) =
d Nhl(t)
~S(0)(t; ^)
; (12)
an estimate for the symmetric matrix  is given by (the detailed calculation is given
in Section 2 of the supplementary le)
^ =
0BBBB@
^; ^; ^;
^0; ^; ^;
^0; ^
0
; ^;
1CCCCA
where
^; = n
 1X
i
X
hl
Z 1
0
24 ~S(2);;hl(t; ^)
~S
(0)
hl (t; ^)
 
~S
(1)
;hl(t; ^)
2
~S
(0)
hl (t; ^)
2
35 d ~N ihl(t) +dVar(Fi);
^; = n
 1
nX
i=1
X
hl
Z 1
0
24 ~S(2);;hl(t; ^)
~S
(0)
hl (t; ^)
 
0@ ~S(1);hl(t; ^)
~S
(0)
hl (t; ^)
1A235 d ~N ihl(t) +dVar(Ei)
^; = n
 1
nX
i=1
X
hl
Z 1
0
24 ~S(2);;hl(t; ^)
~S
(0)
hl (t; ^)
 
~S
(1)
;hl(t; ^)
~S
(1)
;hl(t; ^)
~S
(0)
hl (t; ^)
2
35 d ~N ihl(t)
+dCov(Ei; Fi)
withdVar(Fi),dVar(Ei) and dCov(Ei; Fi) as the sample variances and covariance of Fi(^; ^2)
and Ei(^; ^
2) (i = 1;    ; n such that ni > q + 1), respectively.
The elements in ^; are given by
^;hl = n
 1
Z 1
0
24  0
mi(t) +Hi(t)

+
0@ ~S(2);;hl(t; ^)
~S
(0)
hl (t; ^)
 
~S
(1)
;hl(t; ^)
~S
(1)
;hl(t; ^)
~S
(0)
hl (t; ^)
2
1A35 d ~N ihl(t):
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The elements in ^; are given by
^;hl = n
 1
nX
i=1
Z 1
0
24^hlbi(t) +
0@ ~S(2);;hl(t; ^)
~S
(0)
hl (t; ^)
 
~S
(1)
;hl(t; ^)
~S
(1)
;hl(t; ^)
~S
(0)
hl (t; ^)
2
1A35 d ~N ihl(t):
The elements in the diagonal blocks of ^;
^hl;hl = n
 1
Z 1
0
264
0B@ 0 0
0 ^2bi(t)
1CA+ ~S(2);;hl(t; ^)
~S
(0)
hl (t; ^)
 
0@ ~S(1);hl(t; ^)
~S
(0)
hl (t; ^)
1A
2
375 d ~N ihl(t)
and the other elements in ^; are 0s.
Then using the rst-order Taylor expansion for the estimation equations, we obtain that
the asymptotic distribution for
p
n(^   ) is N (0;D 1(D0) 1), where D is the
limit of @U()=@. We then can easily have an estimate for the covariance matrix of ^,
with ^ given above and an estimate for D as D^ =
@U()
@

=^
, which is given in Section
1 of the supplementary le.
Note that the estimate in (12) for hl;0 is also consistent and
p
n(^hl;0(t) hl;0(t)) has
asymptotic distribution N(0; 2hl(t)). The variance 
2
hl(t) can be estimated as ^
2
hl(t) =R t
0
~S
(0
hl(t; ^)
 1d^hl;0(t)+gt(^)0D^ 1^(D^0) 1gt(^), where gt() =
R t
0
@ ~S(0)(t;)
@
~S
(0
hl(t;)
 1d^hl;0(t).
This result follows from the standard martingale theory and one may see Chapter 8 of
Fleming and Harrington (1991) for more details.
4 Simulation Studies
4.1 Linear random eect process (t)
Scenario 1. Simulation studies were carried out to check the performance of the pa-
rameter estimators. We choose the longitudinal model with q = 1, i.e. i(t) = vi0+ vi1t,
where random intercept vi0 and random slope vi1 mimic the subject-specic baseline
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disease severity and disease progression rate, respectively (Luo, 2014). The random
eects v = (v0; v1) were generated from a bivariate normal distribution with mean
(0:3; 0:5). The random eects v0 and v1 have standard deviation 0:15 and 0:1 respec-
tively and a correlation 0:1. The covariate W is chosen as univariate and generated
from a Bernoulli distribution with p = 0:5. The baseline hazard rate was chosen as
01(t) = exp( 3:0 + 0:2t), 02(t) = exp( 4:0 + 0:05t) and 12(t) = 1:0, the censoring
variable is C = 10 plus an exponential variable with mean 5. This gives a 40% censoring
or so. When generating the longitudinal observations we use HfN i01(t)g = N i01(t).
The sample sizes were chosen as n = 200; 400. All the simulation results in this section
are based on 200 Monte Carlo replications. We take longitudinal measurements at every
0:2 unit time when t <= 1 and at every 0:5 unit time when t > 1. This gives that 95%
subjects have more than 2 longitudinal observations (ni > 2) and will contribute to the
estimating equations. Even when there are only 85% of subjects having ni > 2, the
method still works well. More simulation studies on this and details of how the survival
data are generated are provided in the supplementary le.
Table 1 presents the true parameter values, the estimates, Monte Carlo standard devia-
tion (SD), and mean of standard error estimates (SE) and the coverage probabilities for
the estimates based on the new methods. We can see from the results that the proposed
estimator is practically unbiased. Also the Monte Carlo standard errors agree with the
estimated standard errors. This is one of the advantages of the proposed method, which
can provide a consistent standard error estimate for the estimated parameters. Exist-
ing methods, such as Sun et al. (2012), use bootstrap or other Monte Carlo resampling
methods to compute the standard errors which may not be computationally feasible for
large data sets. The coverage probabilities of the 95% condence intervals are also rea-
sonable. As the sample size increases from 200 to 400, the performance of the proposed
estimator becomes better.
Table 1 is about here.
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The baseline transition rate estimates and the Monte Carlo errors based on the two-
hundred simulations are presented in Figure 1. It shows that the baseline estimates are
also consistent.
Figure 1 is about here.
Some existing research works use parametric methods to model the random eects and
integrate out the unknown random eects from the likelihood function in order to es-
timate the parameters. For example, Dantan et al. (2011) considered a scenario where
a change-point exists for biomarker and used two dierent linear models (two stages,
before and after the change point) to model the longitudinal data. If we rewrite the
longitudinal model (1) as
Yi(t) = i(t) + i(t); if t < Ri
Yi(t) = i(t) + i(t) + ; if t  Ri; (13)
then the parametric approach by integrating out the Gaussian random eects can be
applied directly. When comparing our method with this approach, we found out that the
parametric approach provides similar results to our method, when the random eects
are indeed normally distributed (See Table 1). The parametric results even have smaller
standard errors, comparing to the working likelihood results. This is not surprising
since the parametric method uses the correct Gaussian distribution assumption for the
random eects. However, when the random eects are not normally distributed, the
parametric methods provide worse results and this is shown in the following simulations
studies.
Scenario 2. Now we study the performance of the working likelihood approach under
dierent random eect distributions. We generate vi0; vi1 from two independent uniform
distributions U [0:1; 0:5] and U [0:3; 0:7]. The censoring percentage is about 40%. The
simulation results are shown in Table 2. We can see that results based on the working-
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likelihood approach are as good as those in Table 1. This is because the proposed
working-likelihood method does not require any distribution assumption on the random
eect v. However, if we use parametric methods with the Gaussian assumption for the
random eects, some parameter estimates (those non-zero parameter estimates) have
larger bias. This is shown in Table 2.
Table 2 is about here.
Scenario 3. In some cases the parametric approach performs much worse than the
proposed working likelihood method. We now consider a more extreme case where vi0; vi1
are generated from mixtures of normal distributions, vi0  0:5N(0; 0:01)+0:5N(0:1; 0:01)
and vi1  0:5N(0:05; 0:01) + 0:5N(0:25; 0:01). All other parameter settings remain the
same as the previous simulation studies. The censoring percentage is 50% or so. The
simulation results are shown in Table 3. We can see that the parametric method provides
much larger bias for all parameters. For example, the parametric approach seems not
to give a correct estimate for 01 and 02. However the working-likelihood approach is
very reliable and seems not to be aected by the random eect distribution.
Table 3 is about here.
Scenario 4. For comparison, we also present the result based on  = 0 to compare
the eects when informative censoring is not taken into account. Table 4 presents the
results when the model is misspecied with  = 0. We can see the larger bias and poor
coverage probability in terms of the estimation for the parameters hl and 
2. This is
because without  the link process vi0 + vi1t will be estimated with bias and therefore
its associated parameter  will be estimated with bias.
Table 4 is about here.
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4.2 Higher-order polynomials for (t)
Theoretically the proposed method require that a large proportion of subjects having
ni > q + 1, which may limit the applicability of this method. However, practically if
ni  q + 1 we may still estimate the trajectory of i(t) via a lower-order polynomial.
For example, if we choose q = 3 then i(t) should be a 3rd-order polynomial. But for all
subjects with ni  q + 1, we can still estimate i(t) via a quadratic or linear function.
Such an approach only requires that the majority of subjects have no less than 3 repeated
observations. Note that if most subjects have only one or two longitudinal observations,
it would not make much sense to use a random process to model the biomarker eects.
Therefore it is reasonable to focus on problems where most subjects have enough number
of longitudinal observations.
In this section we consider a simulation study of q = 3. We choose the same true
parameter values as before. The random eects vi;0; vi;1; vi;2; vi;3 are chosen as indepen-
dent multivariate Gaussian variables, with means ( 0:2; 0:5; 0:6; 0:04) and variances
(0:02; 0:01; 0:002; 0:0001). In this simulation study there are only about 50% subjects
having more than 4 observations. However, about 95% subjects have more than 2 ob-
servations. Therefore, most subjects are included in the working likelihood: some of
them (with ni = 3) use linear random eect processes, some of them (with ni = 4) use
quadratic random eect processes and some (with ni > 4) use a polynomial function of
order 3. We can see from the simulation results in Table 5 that the working-likelihood
method still works well.
Table 5 is about here.
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5 Data Analysis
Now we apply the proposed approach to the PBC study discussed earlier. In this ran-
domized clinical trial, 158 out of 312 patients took the drug D-penicillamine, whereas
the other patients were assigned to a control group. Lab test results such as serum
bilirubin were measured at the time of recruitment and at follow-up visits, recorded un-
til death or censoring. The observed event time ranges from 41 to 5225 days. Among the
312 subjects, 125 deaths are observed and the others are censored. The measurement
times of serum bilirubin are specied visits at 6 months, 1 year, and annually thereafter.
About 85% of patients have no more than 10 longitudinal observations. Following (Luo,
2014), we consider the linear biomarker process i(t) = vi0 + vi1t in case of over tting.
Also about 85% of patients have no less than 3 longitudinal observations, which can
contribute to the estimation.
There are 56 patients who have an extra visit. In such an extra visit, patients usually have
an abnormal bilirubin values. Several patients' longitudinal observations are plotted in
Figure 2. From this plot, we can see that their last bilirubin level is unexpectedly higher
than the trend from previous values. These show the worsening medical condition of the
patients. Indeed, among these extra-visit patients, 51 of them have observed death.
Figure 2 is about here.
The original data were studied in Fleming and Harrington (1991) based on only baseline
covariates, and their conclusion was that the drug D-penicillamine is not eective and
some baseline covariates, such as bilirubin, are signicant. Ding and Wang (2008) further
analysed the data based on the longitudinal observations for bilirubin. They use a joint
modelling approach to analyse the survival events and longitudinal data. They also
concluded that the drug D-penicillamine is not eective on patient survival but bilirubin
levels are signicant risk factors.
In our analysis for the survival events, we consider a multi-state model in (3), modeling
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transition rate from the initial state (state 0) to the state having the extra visit (state
1), transition rate from having the extra visit to death (state 2) and transition rate from
0 to 2. The covariates in the multi-state model include the longitudinal measurements of
serum bilirubin during the follow-up period and the time-independent treatment. When
modelling the longitudinal events, we consider model (1). These models will allow us to
take into account the eects of the extra visit. Here we mainly focus on explaining the
estimated parameter values, shown in Table 6.
Figure 3 is about here.
Table 6 is about here.
The value  is estimated at 0:490 with standard error 0:12, which is signicant. This
means that at the extra visit, the bilirubin levels are signicantly higher than the lon-
gitudinal observations obtained before. For four typical patients' longitudinal data, we
plot them individually in Figure 3 and show their tted regression line based on our pro-
posed model. The longitudinal observation at the extra visit is plotted via solid `' sign,
which is clearly not on the regression line and shows the worsening medical condition.
The dotted vertical line in Figure 3 shows the jump of the process at the extra visit and
the parameter  can be interpreted as the average of these jumps. Therefore Figure 3
shows that model (1) taking into account the change point would be appropriate.
From Table 6, we have that the estimates ^02 =  0:067 (with se 0:26), which is not
signicant, and ^02 = 0:977 (with se 0:10), which is signicantly unequal to 0. This
means that if there is no extra visit, the drug D-penicillamine is not eective on patient
survival but bilirubin levels are signicant risk factors. This conrms the results in
Fleming and Harrington (1991) and Ding and Wang (2008). Based on the new model,
however, more results can be achieved. For example, we can also analyse the rate of
`extra visit'. The estimates ^01 = 0:264 (with se 0:28), which is not signicant, and
^01 = 0:970 (with se 0:13), which is signicantly unequal to 0. This means that the
treatment does not aect the rate of the extra visit, but higher bilirubin levels will result
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in unexpected visits within a shorter period. This can facilitate clinical managements.
On the other hand, ^12 =  0:543 (with se 1:42) and ^12 =  0:067 (with se 0:35), both of
which are not signicant. This means that if the extra visit happens (medical conditions
become worse), neither the treatment nor the bilirubin level will give signicant eects
on survival. However, the values ^02 =  0:067 and ^12 =  0:543 might suggest that the
treatment has more eects on those patients with worsening conditions. Analysis based
on a larger data set is needed to conrm such an argument.
To assess the adequacy of the proposed model, it is straightforward to apply a graph-
ical method based on martingale residuals, similar to Schoenfeld (1982) and Zeng and
Cai (2010). The martingale residuals for each subject is given by
P
hl
R
d ~N ihl(t)  
~Qihl(t;)dhl;0(t), which can be calculated easily by using the estimated parameter val-
ues. If the multi-state model assumption is reasonable, these residuals should have mean
0 and no correlation with covariates. We nd out that the residual mean is 0:157 and
residual median is  0:009. In addition the following residual plot shows that there is no
relation between residuals and the baseline longitudinal values. Therefore we conclude
that our model is appropriate.
Figure 4 is about here.
6 Discussion
In the paper, we have presented a joint model for multi-state event times and longitu-
dinal data with a random process as a link, when there exist informative observation
times. Our method does not require any distribution assumption on the random eects.
Asymptotically unbiased estimating equations were proposed to obtain parameter esti-
mates and their standard errors. The asymptotic covariance can be easily calculated.
Existing corrected score methods or conditional score methods require that the longi-
tudinal process be independent of the data collection times. One contribution of the
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new method is that it extends the corrected score method to the cases with longitudinal
data collected at informative time points. However, it is not straightforward to extend
the conditional score method (Tsiatis and Davidian, 2001), since it is not easy to nd
a suitable sucient statistic when the longitudinal process depends on an extra term
Hi(t). We leave this to a future work.
We here focus on the case where there is only one extra visit. When there are more
than one extra visit, the methodology proposed in this paper still works. In such general
cases, the counting process N01(t) means the number of extra visits up to time t. Then
the three-state transition model proposed in this paper should be revised to a more
general multi-state Markov models. We also need to choose dierent function form
H(N01(t)). As Sun et al. (2005) suggested, H(N(t)) can be chosen as the jumps of N(t)
at a small neighborhood of t. Under such revised models, the martingale estimation
approach in this paper can be applied directly. More research needs to be done to
justify the performance of the proposed working likelihood approach in such general
scenarios. This is left to future work.
In practice, there may be many subjects having very few or even no longitudinal mea-
surements. Sun et al. (2012) also pointed out this as a challenge and suggested that
an inverse probability weight method might work. Such reweighing methods will assign
smaller weights to the subjects with few longitudinal observations and larger weights to
subjects with more longitudinal observations. From the simulation results provided in
the supplementary le (Section 3), we found that our estimators are still very good even
if there are about 15% observations have no more than 2 longitudinal observations. But
it is worth carrying out further research to study how to incorporate the inverse proba-
bility weighted methods into our methods. We leave this as a future work. Nevertheless,
the proposed method is preferable to the approach via dealing with unknown random
eects using EM algorithm, since the EM algorithm requires a particular distribution
assumption for the random eects and will be unstable due to many random eects
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included in the model (Ding and Wang, 2008).
In the proposed model, the parameter  is time-independent. If there are more longitudi-
nal observations, this could be generalized to a model with time-dependent parameters.
In addition, the random errors ij ; j = 1;    ; ni could be dependent, following a multi-
variate normal distribution. It is possible to use the mean-covariance modelling method
in Leng et al. (2010) to estimate the covariance matrix for the longitudinal observations.
We also leave these as future works.
A Notation for S(1) and S(2) and proof of the consistency
We dene
mi(t) :=
d^i(t;)
d
=  (1; t;    ; tq)(T0iTi) 1T0iHi;
d2i (t)
d(2)
= bi(t): (14)
From the denition of S
(0)
hl (t;), we can obtain its derivatives as
~S
(1)
;hl(t;) :=
@ ~S
(0)
hl (t;)
@hl
= n 1
nX
i=1
0B@ W i
^i(t;) + Hi(t)  hl2i (t)
1CA ~Qihl(t;)
~S
(1)
;hl(t;) :=
@ ~S
(0)
hl (t;)
@
= n 1
nX
i=1
hl  (mi(t) +Hi(t))  ~Qihl(t;) (15)
~S
(1)
;hl(t;) :=
@ ~S
(0)
hl (t;)
@(2)
=  n 1
nX
i=1

1
2
2hlbi(t)

~Qihl(t;):
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We can further work out the second derivatives of ~S(0)(t;) with respect to , as
~S
(2)
;;hl(t;) :=
@2 ~S
(0)
hl (t;)
@2
= n 1
nX
i=1
[hl  (mi(t) +Hi(t))]2  ~Qihl(t;)
~S
(2)
;;hl(t;) :=
@2 ~S
(0)
hl (t;)
@@hl
= n 1
nX
i=1

0
mi(t) +Hi(t)

~Qihl(t;) (16)
+n 1
nX
i=1
hl  (mi(t) +Hi(t))
0B@ W i
^i(t;) + Hi(t)  hl2i (t)
1CA  ~Qihl(t;)
~S
(2)
;;hl(t;) :=
@2 ~S
(0)
hl (t;)
@@(2)
=  n 1
nX
i=1
hl  (mi(t) +Hi(t)) 

1
2
2hlbi(t)

 ~Qihl(t;);
and
~S
(2)
;;hl(t;) :=
@2 ~S
(0)
hl (t;)
@2hl
= n 1
nX
i=1
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0B@ 0 0
0  2i (t)
1CA+
0B@ W i
^i(t;) + Hi(t)  hl2i (t)
1CA

2375 ~Qihl(t;)
~S
(2)
;;hl(t;) :=
@ ~S
(0)
hl (t;)
@hl
=  n 1
nX
i=1

0
hlbi(t)

~Qihl(t;)
 n 1
nX
i=1
0B@ W i
^i(t;) + Hi(t)  hl2i (t)
1CA  1
2
2hlbi(t)

 ~Qihl(t;)
~S
(2)
;;hl(t;) :=
@2 ~S
(0)
hl (t;)
@(2)2
= n 1
nX
i=1

1
2
2hlbi(t)
2
~Qihl(t;): (17)
Now we prove the consistency of the estimator ^. Denote the log-likelihood, the sum
of (6) and (7), as Ln() and L() := limn Ln() and u() = limnU(). Noticing that
M ihl(t), dened as dM
i
hl(t) = dN
i
hl(t)   ~Qihl(t;)dhl;0(t) is a martingale with respect
to Gi(t), we have that at the true parameter value , u() = 0. Under certain mild
conditions, we will have that  @u()=@ is positive denite and thus  is the maximum
point for the function L().
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Therefore the maximum point ^ of Ln() converges to the maximum point 
 of L().
Note that the maximum point ^ for Ln() is also the solution of the estimating equations.
The consistency is proved.
References
Andersen P. K., Borgan O., Gill R. D. and Keiding N. (1993). Statistical Models Based
on Counting Processes, Springer-Verlag, New York Inc..
Andersen P. K. and Keiding N. (2002). Multi-state models for event history analysis.
Statistical Methods in Medical Research, 11: 91-115.
Chen Y., Ning J. and Cai C. (2015) Regression analysis of longitudinal data with irregu-
lar and informative observation times. Biostatistics, doi: 10.1093/biostatistics/kxv008.
Dantan E., Joly P., Dartigues J-F. and Jacqmin-Gadda H. (2011) Joint model with
latent state for longitudinal and multistate data. Biostatistics, 12: 723-736.
Ding J. and Wang J-L. (2008). Modeling longitudinal data with nonparametric multi-
plicative random eects jointly with survival data. Biometrics, 64(2): 546-556.
Elasho R. M., Li G. and Li N. (2007). An approach to joint analysis of longitudinal
measurements and competing risks failure time data. Statistics in Medicine, 26: 2813-
2835.
Elasho R. M., Li G. and Li N. (2008) A joint model for longitudinal measurements and
survival data in the presence of multiple failure types. Biometrics, 64:762-771.
Flemming T. R. and Harrington D. P. (1991). Counting Processes and Survival Analysis,
John Wiley & Sons, Inc..
Murtaugh P. A., Dickson E. R., Van Dam G. M., Malinchoc M., Grambsch P. M.,
25
Langworthy A. L., Gips C. H. (1994). Primary biliary cirrhosis: prediction of short-
term survival based on repeated patient visits. Hepatology, 20:126-134.
Han J., Slate E. H. and Pena E. A. (2007). Parametric latent class joint model for a
longitudinal biomarker and recurrent events. Statistics in Medicine, 26:5285-5302.
Han M., Song X., Sun L. and Liu L. (2013) Joint modelling of longitudinal data with
informative observation times and dropouts. Statistica Sinica, Preprint.
Henderson R., Diggle P., Dobson A. (2000). Joint modelling of longitudinal measure-
ments and event time data. Biostatistics, 1:465-480.
Huang, C. Y., Wang, M. C., and Zhang, Y. (2006) Analyzing panel count data with
informative observation times, Biometrika, 93: 763-775.
Leng C., Zhang W. and Pan J. (2010) Semiparametric Mean-Covariance Regression
Analysis for Longitudinal Data, Journal of the American Statistical Association, 105:
181-193.
Liang Y., Lu W., and Ying Z. (2009) Joint modeling and analysis of longitudinal data
with informative observation times, Biometrics, 65: 377-384.
Lin, H., Scharfstein, D. O., and Rosenheck, D. O. (2004) Analysis of longitudinal data
with irregular outcome-dependent follow-up. Journal of the Royal Statistical Society,
Series B, 66: 791-813.
Liu, L., Huang X., and O'Quigley J. (2008) Analysis of longitudinal data in the presence
of informative observational times and a dependent terminal event, with application
to medical cost data. Biometrics, 64: 950-958.
Luo S. (2014). A Bayesian approach to joint analysis of multivariate longitudinal data
and parametric accelerated failure time. Statistics in medicine, 33, 580-594.
Meira-Machado L., de Una-Alvarez J., Cadarso-Suarez C. and Andersen P. K. (2009).
26
Multi-state models for the analysis of time-to-event data. Statistical Methods in Med-
ical Research, 18:195-222.
Schoenfeld D. (1982) Partial Residuals for the Proportional Hazards Regression Model.
Biometrika, 69:239-241.
Song X. and Wang C.Y. (2008) Semiparametric approaches for joint modeling of longi-
tudinal and survival data with time-varying coecients. Biometrics, 64:557-566.
Sun J., Park D-H, Sun L. and Zhao X. (2005) Semiparametric regression analysis of lon-
gitudinal data with informative observation times. Journal of the American Statistical
Association, 100:882-889.
Sun, J., Sun, L., and Liu, D. (2007) Regression Analysis of longitudinal data in the
presence of informative observation and censoring times, Journal of the American
Statistical Association, 102: 1397-1406.
Sun, L., Song, X., Zhou J. and Liu, L. (2012) Joint analysis of longitudinal data with in-
formative observation times and a dependent terminal event, Journal of the American
Statistical Association, 107: 688-700.
Tisiatis A. A. and Davidian M. (2001). A semiparametric estimator for the proportional
hazards model with longitudinal covariates measured with error. Biometrika, 88:447-
458.
Tsiatis A. A. and Davidian M. (2004). Joint modeling of longitudinal and time-to-event
data: an overview. Statistica Sinica, 14:809-834.
Wang C. Y. (2006). Corrected score estimator for joint modeling of longitudinal and
failure time data. Statistica Sinica, 16:235-253.
Zeng D. and Cai J. (2010). A semiparametric additive rate model for recurrent events
with an informative terminal event. Biometrika, 97:699-712.
27
The new working-likelihood approach
n = 200  01 01 02 02 12 12 
2
True 0:5 0:0 0:3 0:0 0:7  0:5 0:3 0:09
Estimates 0:505  0:054 0:314  0:036 0:671  0:507 0:279 0:089
SE 0:037 0:184 0:164 0:239 0:227 0:302 0:161 0:0026
SD 0:038 0:190 0:171 0:233 0:239 0:298 0:166 0:0025
CP 0:94 0:94 0:95 0:96 0:93 0:96 0:94 0:94
n = 400  01 01 02 02 12 12 
2
Estimates 0:497 0:028 0:294 0:024 0:707  0:506 0:289 0:090
SE 0:025 0:128 0:144 0:181 0:203 0:246 0:137 0:0021
SD 0:022 0:122 0:147 0:187 0:196 0:255 0:140 0:0020
CP 0:96 0:96 0:94 0:94 0:95 0:95 0:93 0:94
The Parametric Gaussian random eect approach
n = 400  01 01 02 02 12 12 
2
Estimates 0:494 0:021 0:312 0:011 0:685  0:486 0:290 0:090
SE 0:021 0:098 0:120 0:118 0:199 0:164 0:127 0:0020
SD 0:019 0:102 0:119 0:121 0:195 0:175 0:119 0:0019
CP 0:95 0:96 0:94 0:96 0:94 0:97 0:94 0:95
Table 1: Simulation studies; scenario 1; normal random eects. SE: mean of standard er-
ror estimates; SD: Monte Carlo standard deviation of the estimates across the simulated
data sets; CP: coverage probability.
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The new working-likelihood approach
True 0:5 0:0 0:3 0:0 0:7  0:5 0:3 0:09
n = 200  01 01 02 02 12 12 
2
Estimates 0:496 0:002 0:310 0:009 0:680  0:467 0:274 0:091
SE 0:042 0:138 0:113 0:106 0:150 0:105 0:075 0:004
SD 0:041 0:144 0:117 0:110 0:143 0:107 0:081 0:004
CP 0:93 0:93 0:97 0:93 0:96 0:94 0:95 0:94
n = 400  01 01 02 02 12 12 
2
Estimates 0:505 0:026 0:296 0:005 0:702  0:504 0:299 0:090
SE 0:031 0:092 0:084 0:081 0:123 0:086 0:061 0:002
SD 0:030 0:094 0:089 0:079 0:126 0:083 0:060 0:002
CP 0:95 0:96 0:96 0:94 0:93 0:96 0:95 0:95
The Parametric Gaussian random eect approach
n = 400  01 01 02 02 12 12 
2
Estimates 0:506  0:010 0:290 0:014 0:728  0:487 0:286 0:090
SE 0:030 0:082 0:82 0:077 0:119 0:061 0:054 0:002
SD 0:030 0:086 0:085 0:074 0:110 0:067 0:050 0:002
CP 0:94 0:96 0:93 0:97 0:94 0:97 0:94 0:96
Table 2: Simulation studies; scenario 2; uniform random eects. SE: mean of stan-
dard error estimates; SD: Monte Carlo standard deviation of the estimates across the
simulated data sets; CP: coverage probability.
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The new working-likelihood approach
True 0:5 0:0 0:3 0:0 0:7  0:5 0:3 0:09
n = 200  01 01 02 02 12 12 
2
Estimates 0:477 0:010 0:312  0:019 0:675  0:528 0:276 0:089
SE 0:067 0:228 0:182 0:189 0:192 0:239 0:165 0:009
SD 0:075 0:220 0:191 0:202 0:183 0:244 0:163 0:010
CP 0:96 0:93 0:96 0:97 0:93 0:96 0:94 0:97
n = 400  01 01 02 02 12 12 
2
Estimates 0:490 0:005 0:290 0:020 0:682  0:516 0:291 0:090
SE 0:052 0:185 0:171 0:187 0:167 0:133 0:149 0:0083
SD 0:057 0:182 0:163 0:179 0:165 0:142 0:147 0:0085
CP 0:92 0:96 0:93 0:95 0:95 0:96 0:95 0:96
The Parametric Gaussian random eect approach
n = 400  01 01 02 02 12 12 
2
Estimates 0:534  0:010 0:232 0:005 0:647  0:468 0:285 0:080
SE 0:052 0:198 0:113 0:237 0:255 0:171 0:062 0:002
SD 0:054 0:206 0:109 0:242 0:224 0:193 0:071 0:002
CP 0:90 0:96 0:85 0:96 0:90 0:91 0:93 0:96
Table 3: Simulation studies; scenario 2; mixture normal random eects. SE: mean of
standard error estimates; SD: Monte Carlo standard deviation of the estimates across
the simulated data sets; CP: coverage probability.
n = 200  01 01 02 02 12 12 
2
True 0.5 0.0 0.3 0.0 0.7 -0.5 0.3 0.09
Estimates - 0:031 0:546 0:015 0:571  0:527 0:027 0:110
SE - 0:161 0:207 0:188 0:223 0:235 0:124 0:03
SD - 0:174 0:192 0:205 0:216 0:217 0:116 0:03
CP - 0:96 0:60 0:96 0:91 0:94 0:92 0:95
Table 4: Simulation studies; ; scenario 3. SE: mean of standard error estimates; SD:
Monte Carlo standard deviation of the estimates across the simulated data sets; CP:
coverage probability.
The new working-likelihood approach
True 0:5 0:0 0:3 0:0 0:7  0:5 0:3 0:09
n = 400  01 01 02 02 12 12 
2
Estimates 0:496 0:035 0:296  0:004 0:695  0:503 0:293 0:090
SE 0:015 0:112 0:117 0:158 0:196 0:138 0:124 0:0016
SD 0:017 0:110 0:115 0:165 0:191 0:145 0:117 0:0018
CP 0:93 0:95 0:93 0:96 0:95 0:96 0:95 0:95
Table 5: Simulation studies; scenario 5; q = 3 and normal random eects. SE: mean of
standard error estimates; SD: Monte Carlo standard deviation of the estimates across
the simulated data sets; CP: coverage probability.
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01 01 02 02 12 12 
2
Estimates 0:490 0:264 0:970  0:067 0:977  0:543  0:067 0:108
Std Errors 0:12 0:28 0:13 0:26 0:10 1:42 0:35 0:005
Table 6: Data analysis, estimates and their standard errors.
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Figure 1: The baseline transition rate estimates for simulation scenario 1. Solid line: the
true baseline; dash line: the estimated baseline; dot-dash line: the Monte Carlo error
based on the simulation results; dotted line: the mean of the replicated standard error
estimates.
31
0 2 4 6 8 10 12
0
1
2
3
4
5
visit time
log
rith
m 
of 
se
ru
m
 bi
liru
bin
Figure 2: longitudinal observations with the last observation in the extra visit
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Figure 3: The regression ts for the longitudinal observations, by taking into account
that the last visit time is informative.
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Figure 4: Residual plots for model validation.
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